Cytosorbents (CTSO) Q2 2021 Earnings Report

493 Followers

CTSO Q2 2021 EPS Results

Actual EPS: -$0.11
Consensus EPS: -$0.05
Beat/Miss: Missed by -$0.06
One Year Ago EPS: -$0.08

CTSO Q2 2021 Revenue Results

Actual Revenue: $12.02M
Expected Revenue: $12.27M
Beat/Miss: Missed by -$244.93K
YoY Revenue Growth: +22.76%

Earnings Announcement Details

Quarter: Q2 2021
Date: 08/03/2021
Time: After Close
Conference Call: Tuesday, August 3, 2021

CTSO Upcoming Earnings

Cytosorbents's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

CTSO Earnings History

CTSO earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Nov 12, 2026	2026 (Q3)	-0.90-	-0.8	―	―
Aug 06, 2026	2026 (Q2)	-0.90-1.40	0.6	-333.33% (-2.00)
May 13, 2026	2026 (Q1)	-1.10-1.00	-0.4	-150.00% (-0.60)
Mar 25, 2026	2025 (Q4)	-1.00-1.80	-2.8	35.71% (+1.00)
Nov 13, 2025	2025 (Q3)	-0.80-0.80	-0.8	0.00% (+0.00)
Aug 07, 2025	2025 (Q2)	-1.130.60	-1.6	137.50% (+2.20)
May 14, 2025	2025 (Q1)	―-0.02	-2.4	99.17% (+2.38)
Mar 31, 2025	2024 (Q4)	-1.40-0.40	-2.4	83.33% (+2.00)
Nov 07, 2024	2024 (Q3)	-1.27-0.80	-4.2	80.95% (+3.40)
Aug 13, 2024	2024 (Q2)	-1.95-1.60	-2.8	42.86% (+1.20)
May 09, 2024	2024 (Q1)	-2.40-2.40	-3.4	29.41% (+1.00)
Mar 14, 2024	2023 (Q4)	-2.75-2.40	-0.2	-1100.00% (-2.20)
Nov 09, 2023	2023 (Q3)	-2.47-4.20	-5.6	25.00% (+1.40)
Aug 01, 2023	2023 (Q2)	-2.26-2.80	-5	44.00% (+2.20)
May 02, 2023	2023 (Q1)	-2.53-3.40	-4.2	19.05% (+0.80)
Mar 09, 2023	2022 (Q4)	-3.36-0.20	-4.2	95.24% (+4.00)
Nov 03, 2022	2022 (Q3)	-3.30-5.60	-3	-86.67% (-2.60)
Aug 02, 2022	2022 (Q2)	-0.13-0.25	-0.11	-127.27% (-0.14)
May 03, 2022	2022 (Q1)	-0.14-0.21	-0.1	-110.00% (-0.11)
Mar 08, 2022	2021 (Q4)	-0.13-0.21	0	―
Nov 04, 2021	2021 (Q3)	-0.12-0.15	-0.02	-650.00% (-0.13)
Aug 03, 2021	2021 (Q2)	-0.05-0.11	-0.08	-37.50% (-0.03)
May 04, 2021	2021 (Q1)	―-0.10	-0.1	0.00% (+0.00)
Mar 09, 2021	2020 (Q4)	―0.00	-0.13	100.00% (+0.13)
Nov 04, 2020	2020 (Q3)	―-0.02	-0.21	90.48% (+0.19)
Aug 04, 2020	2020 (Q2)	―-0.08	-0.11	27.27% (+0.03)
May 05, 2020	2020 (Q1)	―-0.10	-0.15	33.33% (+0.05)
Mar 05, 2020	2019 (Q4)	―-0.13	-0.17	23.53% (+0.04)
Nov 05, 2019	2019 (Q3)	―-0.21	-0.1	-110.00% (-0.11)
Aug 06, 2019	2019 (Q2)	―-0.11	-0.19	42.11% (+0.08)
May 07, 2019	2019 (Q1)	―-0.15	-0.1	-50.00% (-0.05)
Mar 07, 2019	2018 (Q4)	―-0.17	-0.16	-6.25% (-0.01)
Nov 06, 2018	2018 (Q3)	―-0.10	-0.07	-42.86% (-0.03)
Aug 02, 2018	2018 (Q2)	―-0.19	-0.04	-375.00% (-0.15)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Cytosorbents earnings date